GORDON CARL L
Insider CIK 1282930 · SELB Director, 10% owner · ASNS Director, 10% owner · TPTX Director · NTLA Director, 10% owner · ALEC Director, 10% owner · KROS Director · ARMO Director, 10% owner · PRVL Director, 10% owner · ACET Director, 10% owner · NONE Director, 10% owner · PHGE 10% owner · THRX Director, 10% owner · MBX Director, 10% owner · ORIC Director, 10% owner · KNTE Director, 10% owner · ADRX Director, 10% owner · GMTX Director, 10% owner · TERN Director, 10% owner · BLSM Director · SCTX Director · AVBP Director, 10% owner · NONE Director · ETRA Director, 10% owner · AMRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 7,127,019 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 61,516 | $17.00 | $1.05M | 9,292,025 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 9,230,509 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 8,974,061 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 8,460,994 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 588,235 | $17.00 | $10.00M | 588,235 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 300,249 | $17.00 | $5.10M | 14,325,529 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 14,025,280 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 13,461,093 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 12,691,492 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 10,690,530 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 256,448 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 513,067 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 1,333,975 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 7,127,019 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 564,187 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 769,601 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 2,000,962 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion deriv | 2026-09-28 | 2026-09-30 | 10,690,530 | — | $0 | 0 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 588,235 | $17.00 | $10.00M | 588,235 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 61,516 | $17.00 | $1.05M | 9,292,025 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 256,448 | — | — | 9,230,509 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 513,067 | — | — | 8,974,061 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 1,333,975 | — | — | 8,460,994 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 7,127,019 | — | — | 7,127,019 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | P Buy | 2026-09-28 | 2026-09-30 | 300,249 | $17.00 | $5.10M | 14,325,529 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 564,187 | — | — | 14,025,280 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 769,601 | — | — | 13,461,093 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 2,000,962 | — | — | 12,691,492 | SEC↗ |
| ADRX ADARx Pharmaceuticals, Inc | C Conversion | 2026-09-28 | 2026-09-30 | 10,690,530 | — | — | 10,690,530 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 2,002,310 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 3,090,244 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 4,793,558 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 758,279 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,703,314 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 1,087,934 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-23 | 2,002,310 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 1,000,000 | $15.00 | $15.00M | 1,758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 758,279 | — | — | 758,279 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | P Buy | 2026-09-21 | 2026-09-23 | 333,333 | $15.00 | $5.00M | 5,126,891 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,703,314 | — | — | 4,793,558 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 1,087,934 | — | — | 3,090,244 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-23 | 2,002,310 | — | — | 2,002,310 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,039,996 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,049,283 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | P Buy | 2026-08-10 | 2026-08-12 | 625,000 | $16.00 | $10.00M | 2,714,279 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-12 | 1,039,996 | — | $0 | 1,039,996 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-12 | 1,049,283 | — | $0 | 2,089,279 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,049,283 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,039,996 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | P Buy | 2026-08-10 | 2026-08-12 | 625,000 | $16.00 | $10.00M | 2,714,279 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-12 | 1,049,283 | — | — | 2,089,279 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-12 | 1,039,996 | — | — | 1,039,996 | SEC↗ |
| BLSM BlossomHill Therapeutics, | A Award deriv | 2026-08-06 | 2026-08-10 | 23,904 | — | $0 | 23,904 | SEC↗ |
| BLSM BlossomHill Therapeutics, | A Award deriv | 2026-08-06 | 2026-08-10 | 23,904 | — | $0 | 23,904 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion deriv | 2026-07-27 | 2026-07-29 | 2,065,672 | — | $0 | 0 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion | 2026-07-27 | 2026-07-29 | 348,825 | — | $0 | 348,825 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | P Buy | 2026-07-27 | 2026-07-29 | 1,000,000 | $15.00 | $15.00M | 1,348,825 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion deriv | 2026-07-27 | 2026-07-29 | 2,065,672 | — | $0 | 0 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | P Buy | 2026-07-27 | 2026-07-29 | 1,000,000 | $15.00 | $15.00M | 1,348,825 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion | 2026-07-27 | 2026-07-29 | 348,825 | — | — | 348,825 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | A Award deriv | 2026-07-23 | 2026-07-27 | 14,725 | — | $0 | 14,725 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | D To issuer | 2025-11-21 | 2025-12-18 | 140,057 | $17.75 | $2.49M | 759,155 | SEC↗ |
| KROS Keros Therapeutics, Inc. | D To issuer | 2025-11-21 | 2025-12-18 | 74,465 | $17.75 | $1.32M | 45,057 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 10,500 | — | $0 | 10,500 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2025-06-04 | 2025-06-06 | 5,250 | — | $0 | 5,250 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | S Sale | 2025-04-09 | 2025-04-11 | 3,571,428 | $1.59 | $5.68M | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-18 | 2025-02-19 | 94,100 | $10.84 | $1.02M | 747,887 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-18 | 2025-02-19 | 49,070 | $10.84 | $531.9K | 3,255,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-14 | 2025-02-19 | 17,962 | $9.90 | $177.8K | 3,176,390 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-14 | 2025-02-19 | 29,540 | $9.85 | $291.0K | 3,205,930 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2025-02-11 | 2025-02-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 389,078 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 215,146 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 230,753 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 323,916 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 74,613 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 230,753 | $3.60 | $830.7K | 1,158,893 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 479,736 | $4.00 | $1.92M | 2,522,136 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 808,894 | $4.00 | $3.24M | 2,042,400 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 74,613 | $3.60 | $268.6K | 1,233,506 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 155,120 | $4.00 | $620.5K | 2,677,256 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 389,078 | $3.60 | $1.40M | 928,140 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 215,146 | $3.20 | $688.5K | 539,062 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 323,916 | $3.20 | $1.04M | 323,916 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,372,634 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 4,854,368 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 19,587,284 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 403,787 | — | $0 | 403,787 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 2,658,428 | — | $0 | 2,658,428 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 250,000 | $16.00 | $4.00M | 653,787 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,158,428 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 26,400 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 30,000 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 18,500 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 29,400 | $44.01 | $1.29M | 119,522 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 220,600 | $44.01 | $9.71M | 899,212 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 556 | $10.00 | $5.6K | 1,967,924 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 623 | $10.00 | $6.2K | 755,635 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-16 | 2024-07-17 | 4,009 | $10.00 | $40.1K | 4,839,412 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 6,142 | $10.00 | $61.4K | 756,258 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 5,401 | $10.00 | $54.0K | 1,968,480 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-07-15 | 2024-07-17 | 39,433 | $10.00 | $394.3K | 4,843,421 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2024-07-01 | 2024-07-02 | 4,676 | — | $0 | 4,676 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2024-06-10 | 2024-06-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2024-06-05 | 2024-06-07 | 5,900 | — | $0 | 11,800 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PHGE BiomX Inc. | X Exercise deriv | 2024-05-15 | 2024-05-20 | 9,280,408 | — | $0 | 0 | SEC↗ |
| PHGE BiomX Inc. | X Exercise | 2024-05-15 | 2024-05-20 | 9,280,408 | $0.24 | $2.23M | 13,797,997 | SEC↗ |
| PHGE BiomX Inc. | S Sale | 2024-05-15 | 2024-05-20 | 24,344 | $0.38 | $9.3K | 13,773,653 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 40,501 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 25,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,339 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 450,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 84,599 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,338 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 4,738,453 | — | $0 | 0 | SEC↗ |
| PHGE BiomX Inc. | P Buy deriv | 2024-03-15 | 2024-03-19 | 4,327 | — | $0 | 4,327 | SEC↗ |
| PHGE BiomX Inc. | P Buy deriv | 2024-03-15 | 2024-03-19 | 2,163,500 | — | $0 | 2,163,500 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | D To issuer deriv | 2024-02-14 | 2024-02-14 | 3,250 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 650,600 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 17,063,000 | — | $0 | 0 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2024-02-09 | 2024-02-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,841,100 | $2.40 | $4.42M | 7,526,359 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,041,700 | $2.40 | $2.50M | 1,255,985 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 242,200 | $2.40 | $581.3K | 990,254 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 26,400 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 30,000 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 328,482 | $3.05 | $1.00M | 17,063,000 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 151,450 | $3.05 | $461.9K | 650,600 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 125,000 | $2.09 | $261.2K | 1,027,885 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 250,000 | $2.09 | $522.5K | 646,657 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 442,000 | $2.09 | $923.8K | 5,685,259 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 58,000 | $2.09 | $121.2K | 748,054 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-13 | 3,250 | — | $0 | 3,250 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-13 | 19,500 | — | $0 | 19,500 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-06-01 | 2023-06-02 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2023-06-01 | 2023-06-02 | 5,900 | — | $0 | 5,900 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,511 | $2.82 | $1.38M | 1,368,338 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,512 | $2.82 | $1.38M | 1,368,339 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 312,991 | $2.75 | $860.7K | 4,738,453 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 220,610 | $2.67 | $589.0K | 4,425,462 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,544 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,545 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 467,068 | $2.62 | $1.22M | 4,204,852 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,998 | $2.55 | $155.5K | 610,998 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 228,754 | $2.55 | $583.3K | 3,737,784 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,997 | $2.55 | $155.5K | 610,997 | SEC↗ |
| PHGE BiomX Inc. | P Buy deriv | 2023-02-27 | 2023-03-17 | 1,789,959 | — | $0 | 1,789,959 | SEC↗ |
| PHGE BiomX Inc. | P Buy | 2023-02-27 | 2023-03-17 | 348,000 | $0.25 | $87.0K | 3,161,489 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-22 | 550,000 | — | $0 | 550,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-22 | 550,000 | — | $0 | 550,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2023-02-08 | 2023-02-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-12-23 | 2022-12-28 | 137,931 | $7.25 | $1000.0K | 4,882,854 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-11-08 | 2022-11-10 | 402,000 | $3.21 | $1.29M | 15,219,994 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-11-07 | 2022-11-09 | 192,000 | $5.21 | $1.00M | 16,734,518 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 64,050 | — | $0 | 64,050 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 207,500 | — | $0 | 207,500 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-18 | 38,450 | — | $0 | 38,450 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 457,400 | $2.42 | $1.11M | 1,973,881 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 2,470,200 | $2.42 | $5.98M | 4,744,923 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-18 | 762,400 | $2.42 | $1.85M | 762,400 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2022-06-16 | 2022-06-21 | 32,000 | — | $0 | 32,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,250 | — | $0 | 20,250 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2022-06-10 | 2022-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 18,500 | — | $0 | 18,500 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 8,293 | — | $0 | 8,293 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-13 | 2022-05-13 | 30,722 | $2.49 | $76.5K | 14,817,994 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-12 | 2022-05-13 | 97,094 | $2.35 | $228.2K | 14,787,272 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-11 | 2022-05-13 | 64,700 | $1.79 | $115.8K | 14,690,178 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-10 | 2022-05-10 | 24,447 | $1.60 | $39.1K | 14,625,478 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-09 | 2022-05-10 | 90,712 | $1.56 | $141.5K | 14,601,031 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-06 | 2022-05-10 | 10,200 | $1.63 | $16.6K | 14,510,319 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2022-02-18 | 2022-02-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-15 | 2022-02-15 | 9,000 | $9.96 | $89.6K | 3,509,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-14 | 2022-02-15 | 10,000 | $9.89 | $98.9K | 3,500,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-14 | 2022-02-15 | 20,700 | $9.98 | $206.6K | 3,490,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-11 | 2022-02-15 | 156,000 | $10.22 | $1.59M | 3,469,330 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-21 | 2022-01-21 | 111,896 | $9.97 | $1.12M | 16,542,652 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-20 | 2022-01-21 | 35,000 | $9.95 | $348.3K | 16,430,756 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-19 | 2022-01-21 | 11,521 | $9.97 | $114.9K | 16,395,756 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-13 | 2022-01-13 | 17,320 | $9.43 | $163.3K | 16,384,235 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-12 | 2022-01-13 | 18,897 | $10.06 | $190.1K | 16,366,915 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-11 | 2022-01-13 | 6,900 | $10.67 | $73.6K | 16,348,018 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-01-11 | 2022-01-13 | 1,600 | $9.81 | $15.7K | 16,341,118 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-12-10 | 2021-12-14 | 214,285 | $14.00 | $3.00M | 242,285 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2021-11-04 | 2021-11-08 | 3,571,428 | $3.50 | $12.50M | 3,571,428 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2021-11-04 | 2021-11-08 | 1,785,715 | $3.50 | $6.25M | 14,500,119 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 873,300 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 436,650 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 14,903,718 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion | 2021-10-12 | 2021-10-14 | 15,777,018 | — | $0 | 15,777,018 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion | 2021-10-12 | 2021-10-14 | 436,650 | — | $0 | 436,650 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2021-10-12 | 2021-10-14 | 562,500 | $16.00 | $9.00M | 16,339,518 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2021-10-12 | 2021-10-14 | 62,500 | $16.00 | $1.00M | 499,150 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2021-10-06 | 2021-10-08 | 22,678 | — | $0 | 22,678 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2021-10-04 | 2021-10-06 | 17,245 | — | $0 | 17,245 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 16,625 | — | $0 | 16,625 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 8,293 | — | $0 | 8,293 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-04-30 | 2021-05-04 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-30 | 2021-03-31 | 27,869 | $23.93 | $666.9K | 2,212,571 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-29 | 2021-03-31 | 75,555 | $23.31 | $1.76M | 2,240,440 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-26 | 2021-03-26 | 27,816 | $23.88 | $664.2K | 2,315,995 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-25 | 2021-03-26 | 51,523 | $24.70 | $1.27M | 2,343,811 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-24 | 2021-03-26 | 32,959 | $24.80 | $817.4K | 2,395,334 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-23 | 2021-03-23 | 3,992 | $24.32 | $97.1K | 2,428,293 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-22 | 2021-03-23 | 7,673 | $26.47 | $203.1K | 2,432,285 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-19 | 2021-03-23 | 21,275 | $26.47 | $563.1K | 2,439,958 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-18 | 2021-03-18 | 6,059 | $28.03 | $169.8K | 2,461,233 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-17 | 2021-03-18 | 18,790 | $28.43 | $534.2K | 2,467,292 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-16 | 2021-03-18 | 41,353 | $27.72 | $1.15M | 2,486,082 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-15 | 2021-03-15 | 89,210 | $29.14 | $2.60M | 2,527,435 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-12 | 2021-03-15 | 90,521 | $30.29 | $2.74M | 2,616,645 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 58,551 | $33.04 | $1.93M | 2,707,166 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2021-02-24 | 2021-02-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 104,050 | $13.00 | $1.35M | 396,657 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 420,299 | $13.00 | $5.46M | 5,243,259 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 714,285 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 918,295 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,071,428 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 612,196 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 285,000 | $17.00 | $4.84M | 2,274,723 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 1,989,723 | — | $0 | 1,989,723 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 1,326,481 | — | $0 | 1,326,481 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 190,000 | $17.00 | $3.23M | 1,516,481 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 17,000 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | U Tender | 2021-01-22 | 2021-01-26 | 13,822,463 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 118,398 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 9,461 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 50,501 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 24,555 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 243,494 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 2,651,042 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 118,794 | — | $0 | 3,313,330 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 50,501 | — | $0 | 50,501 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 2,651,042 | — | $0 | 3,194,536 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 9,461 | — | $0 | 59,962 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 243,494 | — | $0 | 543,494 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 24,637 | — | $0 | 84,599 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2020-12-02 | 2020-12-04 | 40,501 | — | $0 | 40,501 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2020-12-02 | 2020-12-04 | 300,000 | $20.00 | $6.00M | 300,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2020-12-02 | 2020-12-04 | 450,000 | $20.00 | $9.00M | 450,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 902,885 | — | $0 | 902,855 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 4,822,960 | — | $0 | 4,822,960 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 292,607 | — | $0 | 292,607 | SEC↗ |
| NONE Compass Therapeutics, Inc. | P Buy | 2020-06-19 | 2020-06-23 | 1,455,132 | $5.00 | $7.28M | 12,714,404 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 17,000 | — | $0 | 17,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-06-15 | 2020-06-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion deriv | 2020-04-28 | 2020-04-28 | 373,356 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion deriv | 2020-04-28 | 2020-04-28 | 1,875,000 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion deriv | 2020-04-28 | 2020-04-28 | 236,111 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion | 2020-04-28 | 2020-04-28 | 236,111 | — | $0 | 2,765,717 | SEC↗ |